Innate Pharma SA Adjustments For Share-based Payments
Innate Pharma SA (IPHA) reported Adjustments For Share-based Payments of EUR 2.57 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:AdjustmentsForSharebasedPayments · last filed 2026-04-01
| Period end | Adjustments For Share-based Payments 6 month | Adjustments For Share-based Payments 12 month |
|---|---|---|
| 2025-12-31 | 2.57M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 1.55M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 3.94M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 1.71M EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 4.26M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 1.40M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 4.25M EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 2.60M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 2.62M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 853.00K EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 2.48M EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | 824.00K EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 3.83M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 2.71M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 9.83M EUR 20-F · filed 2020-04-24 |